CasZyme - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 480,302 | 499,615 | 527,546 | 682,133 | 1,816,373 | 2,943,670 | 2,558,701 | 900,000 |
| Profit before tax | - | - | - | - | 587,475 | 710,744 | 294,272 | -1,057,605 |
| Net profit | 158,771 | 33,933 | 80,014 | 231,349 | 587,475 | 710,744 | 294,272 | -1,057,605 |
| Equity | 288,277 | 322,211 | 402,225 | 675,524 | 1,226,500 | 1,938,165 | 2,232,437 | 1,174,832 |
| Liabilities | 13,297 | 21,331 | 27,947 | 81,111 | 102,691 | 267,659 | 196,278 | 133,928 |
| Non-current assets | 92,600 | 57,144 | 7,944 | 1,963 | 23,303 | 61,885 | 210,524 | 72,817 |
| Current assets | 199,012 | 267,653 | 408,429 | 738,631 | 1,355,273 | 2,241,437 | 2,278,532 | 1,201,649 |
| Total assets | 291,612 | 324,797 | 416,373 | 740,594 | 1,378,576 | 2,303,322 | 2,489,056 | 1,274,466 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 115,327 | 54,812 | 148,812 |
| Social insurance contributions | - | - | - | - | - | 178,723 | 233,509 | 262,271 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +105.3% | +4.0% | +5.6% | +29.3% | +166.3% | +62.1% | -13.1% | -64.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 54.4% | 10.4% | 19.2% | 31.2% | 42.6% | 30.9% | 11.8% | -83.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 55.1% | 10.5% | 19.9% | 34.2% | 47.9% | 36.7% | 13.2% | -90.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 33.1% | 6.8% | 15.2% | 33.9% | 32.3% | 24.1% | 11.5% | -117.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 32.3% | 24.1% | 11.5% | -117.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 72,045 | 56,560 | 55,048 | 52,810 | 112,353 | 136,915 | 101,001 | 37,241 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
CasZyme - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-09-19 | 2022-09-19 | 71.97 |
CasZyme - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
CasZyme, UAB (code 304532644) is a Private Limited Liability Company active in research and experimental development on other natural sciences and engineering. In 2025, the company generated revenue of €900.0K and recorded a net loss of €1.06M, resulting in a profit margin of -117.5%. This followed a marked deterioration from 2024, when revenue was €2.56M and net profit was €294.3K, and from 2023, when revenue reached €2.94M and net profit was €710.7K. Over the latest two years, revenue declined by 64.8% year on year and by 69.4% over two years. At the end of 2025, total assets stood at €1.27M, equity at €1.17M and liabilities at €133.9K. The equity ratio remained high at 92.2%, while debt-to-equity was 0.11 and asset turnover was 0.71x. Revenue per employee was €37.5K, while profit per employee was negative at -€44.1K, reflecting the weaker 2025 operating result.